Functional brain imaging market seen reaching $8.7B by 2033

Persistence Market Research says the global functional brain imaging system market will grow from $5.4 billion in 2026 to $8.7 billion by 2033 as demand rises for neurological diagnostics, research tools and AI-enabled imaging. North America leads today, while hospitals and functional MRI systems remain the biggest market anchors.

Why it matters: - Functional brain imaging is becoming a core tool for diagnosing and monitoring neurological disorders. - The market’s growth reflects higher demand for earlier detection, more precise treatment planning and stronger neuroscience research. - Rising use of AI in imaging could improve diagnostic speed and accuracy across hospitals and research centers.

What happened: - Persistence Market Research values the global functional brain imaging system market at US$5.4 billion in 2026. - The firm expects the market to reach US$8.7 billion by 2033. - The forecast implies a 7.2% compound annual growth rate from 2026 to 2033. - The report was released July 13, 2026. - The report includes a free sample at More information. - The company also offers report customization at Customization request. - The full report is available at The full report.

The details: - Functional brain imaging systems let clinicians and researchers study brain activity in real time. - The market is segmented by product type, application, end user and technology. - Product categories include functional MRI, PET, EEG, MEG and other advanced imaging systems. - Functional MRI remains the leading product segment because of its detailed, non-invasive imaging and high diagnostic reliability. - PET and MEG are gaining traction in specialized neurological and cognitive research. - End users include hospitals, diagnostic imaging centers, academic institutions, neuroscience research organizations and specialty clinics. - Hospitals are the largest end-user segment because of heavy neurological exam volume and ongoing investment in imaging infrastructure. - North America is the leading regional market. - Europe also holds a strong market position. - Asia Pacific is expected to post substantial growth during the forecast period. - Key market players include Koninklijke Philips N.V., General Electric Company, Canon Medical Systems Corporation, EB Neuro S.p.A., MinFound Medical Systems Co., Ltd., Neurosoft, Medtronic Plc, Nihon Kohden Corporation, Hitachi Medical Systems, Elekta and Siemens AG.

Between the lines: - The report points to a market where hardware quality still matters, but software and AI are becoming part of the buying decision. - Strong reimbursement, advanced infrastructure and research funding continue to favor North America. - Emerging markets may drive the next wave of adoption as healthcare systems expand diagnostic capacity.

What's next: - Continued product innovation should push more AI-assisted and integrated imaging platforms into clinical use. - Expanding neuroscience research, clinical trials and precision medicine programs are likely to support demand. - Manufacturers may focus on partnerships and upgrades that improve workflow efficiency and diagnostic performance. - Growth in Asia Pacific could accelerate as governments invest in medical technology and diagnostic infrastructure.